Clincosm LogoSign in Get a demo

Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT00205075
Collaborator
(none)
47
Enrollment
1
Location
46
Duration (Months)
1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    47 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Use of Validated Measures of Alcohol Intake to Measure the Impact of Moderate Alcohol Consumption on Hepatic Fibrogenesis in Individuals Infected With Hepatitis C
    Study Start Date :
    Aug 1, 2004
    Actual Primary Completion Date :
    Jun 1, 2008
    Actual Study Completion Date :
    Jun 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    Case
    Control

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately
      Exclusion Criteria:

      • HIV co-infection

      • Treated within the past 6 months

      • History (hx) of other liver disease

      • Alcohol use greater than 30 g/day or history of binge drinking in the last year

      • Decompensated liver disease

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of Wisconsin Madison Wisconsin United States 53792

      Sponsors and Collaborators

      • University of Wisconsin, Madison

      Investigators

      • Principal Investigator: Adnan Said, MD, University of Wisconsin, Madison

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      University of Wisconsin, Madison
      ClinicalTrials.gov Identifier:
      NCT00205075
      Other Study ID Numbers:
      • H-2004-0161
      First Posted:
      Sep 20, 2005
      Last Update Posted:
      Dec 9, 2015
      Last Verified:
      Dec 1, 2015
      Additional relevant MeSH terms:
      Hepatitis A
      Hepatitis C
      Hepatitis

      Study Results

      No Results Posted as of Dec 9, 2015